Sign up
Healthed-White-on-Blue

New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3

Description

In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Richard Harvey

Prof Richard Harvey

Recurrent Nasal Polyps Management – When to Refer

Prof Michelle Giles OAM

Prof Michelle Giles OAM

Practical Strategies to Address Falling Vaccination Rates in Mums and Bubs

Dr Emily Nash

Dr Emily Nash

Abnormal Liver Function Test Interpretation

Prof Kelly-Anne Phillips

Prof Kelly-Anne Phillips

Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

31 March 2026
Register Now
Prof Paul Van Buynder

expert

Prof Paul Van Buynder

Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland

Date published: 25 July 2023

Discover

Healthed

CPD platform